Chemoinformaics analysis of (+)-volkensiflavone
| Molecular Weight | 540.48 | nRot | 3 |
| Heavy Atom Molecular Weight | 520.32 | nRig | 36 |
| Exact Molecular Weight | 540.106 | nRing | 6 |
| Solubility: LogS | -4.698 | nHRing | 2 |
| Solubility: LogP | 4.79 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 5 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 4 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 28 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 29 |
| nHA | 10 | APOL | 71.4559 |
| nHD | 6 | BPOL | 25.2721 |
| QED | 0.186 |
| Synth | 3.767 |
| Natural Product Likeliness | 1.682 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.04 |
| Pgp-sub | 0.001 |
| HIA | 0.746 |
| CACO-2 | -5.489 |
| MDCK | 0.00000603 |
| BBB | 0.001 |
| PPB | 0.977978 |
| VDSS | 0.347 |
| FU | 0.0294634 |
| CYP1A2-inh | 0.678 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.775 |
| CYP2c19-sub | 0.041 |
| CYP2c9-inh | 0.828 |
| CYP2c9-sub | 0.965 |
| CYP2d6-inh | 0.171 |
| CYP2d6-sub | 0.323 |
| CYP3a4-inh | 0.454 |
| CYP3a4-sub | 0.108 |
| CL | 4.421 |
| T12 | 0.371 |
| hERG | 0.038 |
| Ames | 0.699 |
| ROA | 0.888 |
| SkinSen | 0.932 |
| Carcinogencity | 0.088 |
| EI | 0.884 |
| Respiratory | 0.026 |
| NR-Aromatase | 0.949 |
| Antiviral | Yes |
| Prediction | 0.773899 |